it is either the root of all evil- IP spent millions of dollars and lots of time on a lousy guess that higher doses would show some benefit when the P2a data are so weak
or
it is the root of all good- big bump in share price as we begin to partner up for B and of course P, since that study was the valid harbinger of glad tidings
I am still amazed you think it's a winner- are you willing to pick an outcome? Or, do you just enjoy posting the pathetic graph?
I am going with P2 b failure. Are you picking success or just joshing?